RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Marrone Bio Innovations Equity 2024

Marrone Bio Innovations Equity

29.65 M USD

Marrone Bio Innovations Dividend yield

Ticker

MBII

ISIN

US57165B1061

WKN

A1W30B

In 2024, Marrone Bio Innovations's equity was 29.65 M USD, a 0% increase from the 0 USD equity in the previous year.

Marrone Bio Innovations Aktienanalyse

What does Marrone Bio Innovations do?

Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Marrone Bio Innovations's Equity

Marrone Bio Innovations's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Marrone Bio Innovations's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Marrone Bio Innovations's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Marrone Bio Innovations's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Marrone Bio Innovations’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Marrone Bio Innovations Stock

What is the equity of Marrone Bio Innovations this year?

Marrone Bio Innovations has equity of 29.65 M USD this year.

What was the equity of Marrone Bio Innovations compared to the previous year?

The equity of Marrone Bio Innovations has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Marrone Bio Innovations?

A high equity is advantageous for investors of Marrone Bio Innovations as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Marrone Bio Innovations?

A low equity can be a risk for investors of Marrone Bio Innovations, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Marrone Bio Innovations affect the company?

An increase in equity of Marrone Bio Innovations can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Marrone Bio Innovations affect the company?

A reduction in equity of Marrone Bio Innovations can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Marrone Bio Innovations?

Some factors that can affect the equity of Marrone Bio Innovations include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Marrone Bio Innovations so important for investors?

The equity of Marrone Bio Innovations is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Marrone Bio Innovations take to change the equity?

To change equity, Marrone Bio Innovations can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Marrone Bio Innovations pay?

Over the past 12 months, Marrone Bio Innovations paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Marrone Bio Innovations is expected to pay a dividend of 0 USD.

What is the dividend yield of Marrone Bio Innovations?

The current dividend yield of Marrone Bio Innovations is .

When does Marrone Bio Innovations pay dividends?

Marrone Bio Innovations pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Marrone Bio Innovations?

Marrone Bio Innovations paid dividends every year for the past 0 years.

What is the dividend of Marrone Bio Innovations?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Marrone Bio Innovations located?

Marrone Bio Innovations is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Marrone Bio Innovations kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Marrone Bio Innovations from 4/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Marrone Bio Innovations pay the last dividend?

The last dividend was paid out on 4/29/2024.

What was the dividend of Marrone Bio Innovations in the year 2023?

In the year 2023, Marrone Bio Innovations distributed 0 USD as dividends.

In which currency does Marrone Bio Innovations pay out the dividend?

The dividends of Marrone Bio Innovations are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Marrone Bio Innovations

Our stock analysis for Marrone Bio Innovations Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Marrone Bio Innovations Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.